# The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats

> **NCT04163835** · PHASE4 · UNKNOWN · sponsor: **China Academy of Chinese Medical Sciences** · enrollment: 150 (estimated)

## Conditions studied

- Atrial Premature Complexes

## Interventions

- **DRUG:** Normal-dose Wenxin Granules
- **DRUG:** 1/2 Normal-dose Wenxin Granules
- **DRUG:** Twice Normal-dose Wenxin Granules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04163835
- **Lead sponsor:** China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04163835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04163835, "The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04163835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*